# STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer

> **NCT01167114** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 28 (actual)

## Conditions studied

- Esophagogastric Cancer

## Interventions

- **DRUG:** STA-9090

## Key facts

- **NCT ID:** NCT01167114
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2016-05
- **Final completion:** 2017-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167114, "STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01167114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*